• Tamsulosin in Urological Disease Research: Protocols and Ins

  2026-08-03

  Tamsulosin, a selective α₁A-adrenergic receptor antagonist, is transforming urological and smooth muscle research with reliable performance in both clinical and experimental settings. Learn how to optimize protocols and troubleshoot common challenges, backed by the latest meta-analytic evidence and APExBIO’s rigorously characterized compound.

• Spleen-Targeted Neoantigen mRNA Vaccine Induces TLS in HCC

  2026-08-03

  Lin et al. introduce a spleen-targeted neoantigen mRNA vaccine (STNvac) that robustly activates ISG15+ CD8+ T cells and promotes tertiary lymphoid structure formation in hepatocellular carcinoma. This study uncovers new mechanistic insights into mRNA vaccine-based immunotherapy for immune-refractory solid tumors, with implications for the rational design of next-generation cancer vaccines.

• RG7388 MDM2 Antagonist: Applied Protocols & Tumor Model Insi

  2026-08-02

  RG7388, a highly selective MDM2 antagonist supplied by APExBIO, enables robust p53 pathway activation and reproducible cancer cell apoptosis induction in wild-type p53 tumor models. This guide unpacks practical assay workflows, optimization strategies, and evidence-driven use-cases—including combination therapy paradigms and troubleshooting tips.

• BAY-826: Potent Small Molecule Inhibitor in Retinal Research

  2026-08-01

  BAY-826 empowers researchers to dissect neurovascular signaling with unrivaled selectivity and reproducibility, making it indispensable for angiopoietin and pigment epithelium-derived factor (PEDF) pathway studies. Its ultra-low nanomolar potency and optimized handling protocols accelerate troubleshooting and enhance experimental clarity in retinal neuron survival assays.

• Estradiol-ERα Inhibits ER Stress to Restore CD4+ T Cells Aft

  2026-07-31

  This study demonstrates that 17β-estradiol restores splenic CD4+ T lymphocyte function after hemorrhagic shock by inhibiting endoplasmic reticulum stress via ERα and GPR30, but not ERβ. The findings clarify receptor-specific immune restoration mechanisms and inform future research on endocrine modulation and trauma-induced immunosuppression.

• Tamsulosin: Advanced Use-Cases in Urological Disease Researc

  2026-07-31

  Tamsulosin, a selective α₁A-adrenergic receptor antagonist, is redefining urological and smooth muscle research with high solubility and robust clinical evidence. APExBIO’s Tamsulosin (C6445) enables precise modeling of urinary retention and stone expulsion, offering superior workflow reliability for experimental and translational studies.

• Cisapride (R 51619) in Cardiac Electrophysiology Research

  2026-07-30

  Cisapride (R 51619) stands at the intersection of advanced cardiotoxicity modeling and high-throughput drug screening. Its dual action as a 5-HT4 receptor agonist and hERG channel inhibitor makes it indispensable for predictive cardiac safety assessments using iPSC-derived cardiomyocytes.

• MLKL Polymerization Drives Lysosomal Permeabilization in Nec

  2026-07-30

  This study elucidates how MLKL polymerization induces lysosomal membrane permeabilization (LMP), leading to necroptosis via cathepsin release. The findings clarify a critical cell death mechanism relevant for disease modeling and potential therapeutic targeting.

• CNQX: Precision Dissection of Glutamatergic Circuits in Neur

  2026-07-29

  CNQX, or 6-cyano-7-nitroquinoxaline-2,3-dione, delivers targeted inhibition of AMPA and kainate receptors, enabling highly specific analysis of glutamatergic neurotransmission in both in vitro and in vivo models. This article breaks down practical workflows, troubleshooting strategies, and the latest research insights to help researchers harness CNQX for advanced circuit mapping and excitotoxicity studies.

• Hesperadin: Potent Aurora B Kinase Inhibitor for Mitotic Res

  2026-07-29

  Hesperadin is a highly selective Aurora B kinase inhibitor used for dissecting mitotic regulation and spindle assembly checkpoint dynamics. Its ATP-competitive mechanism disrupts chromosome alignment and segregation, making it essential in cancer and cell cycle research.

• Lipidomic Remodeling Drives Ferroptosis Sensitivity in Persi

  2026-07-28

  This study elucidates how reversible lipidomic changes in drug-tolerant persister cancer cells underpin their heightened sensitivity to ferroptosis. The findings provide a mechanistic basis for targeting minimal residual disease and offer new directions for overcoming therapy resistance in solid tumors.

• SB-3CT: Gelatinase Inhibitor Workflows for ECM and Neuroprot

  2026-07-28

  SB-3CT empowers targeted studies of matrix metalloproteinases (MMP-2 and MMP-9), enabling nuanced dissection of tumor metastasis, angiogenesis, and neuronal plasticity. This guide bridges cutting-edge reference findings with actionable protocols and troubleshooting for maximal research impact.

• Berberrubine chloride: Data-Driven Solutions for Cancer Rese

  2026-07-27

  This article presents scenario-driven guidance for deploying Berberrubine chloride (SKU N2089) in advanced cancer and metabolic assays. It addresses real-world workflow pain points, supports evidence-based optimization, and underscores the analytical and cost-efficiency benefits of sourcing from APExBIO for reliable, reproducible results.

• SGC-CBP30: Precision CREBBP/EP300 Bromodomain Inhibitor Work

  2026-07-27

  SGC-CBP30 enables targeted epigenetic interrogation by selectively inhibiting CREBBP/EP300 bromodomains, streamlining advanced cancer biology and transcriptional regulation assays. This article offers actionable protocols, troubleshooting strategies, and unique insights into leveraging SGC-CBP30 for super-enhancer and TGF-β/SMAD3 pathway research.

• CB-839 (Telaglenastat): Optimizing Glutaminolysis Inhibition

  2026-07-26

  CB-839 (Telaglenastat) enables researchers to dissect glutamine metabolism vulnerabilities in cancer models with precision, supporting robust preclinical drug evaluation. This guide delivers actionable protocols and troubleshooting insights, building on the latest mechanistic findings in neuroblastoma metabolism.

8243 records 12/550 page Previous Next First page 上5页 1112131415 下5页 Last page